These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 26676320)

  • 1. DNA prime-protein boost based vaccination with a conserved region of leptospiral immunoglobulin-like A and B proteins enhances protection against leptospirosis.
    Forster KM; Hartwig DD; Oliveira TL; Bacelo KL; Schuch R; Amaral MG; Dellagostin OA
    Mem Inst Oswaldo Cruz; 2015 Dec; 110(8):989-95. PubMed ID: 26676320
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A conserved region of leptospiral immunoglobulin-like A and B proteins as a DNA vaccine elicits a prophylactic immune response against leptospirosis.
    Forster KM; Hartwig DD; Seixas FK; Bacelo KL; Amaral M; Hartleben CP; Dellagostin OA
    Clin Vaccine Immunol; 2013 May; 20(5):725-31. PubMed ID: 23486420
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A prime-boost strategy using the novel vaccine candidate, LemA, protects hamsters against leptospirosis.
    Hartwig DD; Forster KM; Oliveira TL; Amaral M; McBride AJ; Dellagostin OA
    Clin Vaccine Immunol; 2013 May; 20(5):747-52. PubMed ID: 23515012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heterologous DNA prime-protein boost immunization with RecA and FliD offers cross-clade protection against leptospiral infection.
    Raja V; Sobana S; Mercy CSA; Cotto B; Bora DP; Natarajaseenivasan K
    Sci Rep; 2018 Apr; 8(1):6447. PubMed ID: 29691454
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the Leptospira interrogans Outer Membrane Protein OmpL37 as a Vaccine Candidate.
    Oliveira TL; Grassmann AA; Schuch RA; Seixas Neto AC; Mendonça M; Hartwig DD; McBride AJ; Dellagostin OA
    PLoS One; 2015; 10(11):e0142821. PubMed ID: 26588685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune response in hamsters immunised with a recombinant fragment of LigA from Leptospira interrogans, associated with carrier molecules.
    Oliveira TL; Bacelo KL; Schuch RA; Seixas FK; Collares T; Rodrigues OE; Vargas J; Nascimento RO; Dellagostin OA; Hartwig DD
    Mem Inst Oswaldo Cruz; 2016 Nov; 111(11):712-716. PubMed ID: 27759768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LigB subunit vaccine confers sterile immunity against challenge in the hamster model of leptospirosis.
    Conrad NL; Cruz McBride FW; Souza JD; Silveira MM; Félix S; Mendonça KS; Santos CS; Athanazio DA; Medeiros MA; Reis MG; Dellagostin OA; McBride AJ
    PLoS Negl Trop Dis; 2017 Mar; 11(3):e0005441. PubMed ID: 28301479
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of different strategies to promote a protective immune response against leptospirosis using a recombinant LigA and LigB chimera.
    da Cunha CEP; Bettin EB; Bakry AFAAY; Seixas Neto ACP; Amaral MG; Dellagostin OA
    Vaccine; 2019 Mar; 37(13):1844-1852. PubMed ID: 30826147
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunogenicity of a DNA and Recombinant Protein Vaccine Combining LipL32 and Loa22 for Leptospirosis Using Chitosan as a Delivery System.
    Umthong S; Buaklin A; Jacquet A; Sangjun N; Kerdkaew R; Patarakul K; Palaga T
    J Microbiol Biotechnol; 2015 Apr; 25(4):526-36. PubMed ID: 25348693
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of the immunogenicity of the leptospiral LipL32, LigAni, and LigBrep recombinant proteins in the sheep model.
    da Rosa MC; Martins G; Rocha BR; Correia L; Ferronato G; Lilenbaum W; Dellagostin OA
    Comp Immunol Microbiol Infect Dis; 2019 Aug; 65():176-180. PubMed ID: 31300110
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Leptospira immunoglobulin-like protein A variable region (LigAvar) incorporated in liposomes and PLGA microspheres produces a robust immune response correlating to protective immunity.
    Faisal SM; Yan W; McDonough SP; Chang YF
    Vaccine; 2009 Jan; 27(3):378-87. PubMed ID: 19022317
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of Immunoprotection of Leptospira Recombinant Proteins with conventional vaccine in experimental animals.
    Parthiban M; Kumar SS; Balachandran C; Kumanan K; Aarthi KS; Nireesha G
    Indian J Exp Biol; 2015 Dec; 53(12):779-85. PubMed ID: 26742322
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The terminal portion of leptospiral immunoglobulin-like protein LigA confers protective immunity against lethal infection in the hamster model of leptospirosis.
    Silva EF; Medeiros MA; McBride AJ; Matsunaga J; Esteves GS; Ramos JG; Santos CS; Croda J; Homma A; Dellagostin OA; Haake DA; Reis MG; Ko AI
    Vaccine; 2007 Aug; 25(33):6277-86. PubMed ID: 17629368
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of novel fusion proteins derived from extracellular matrix binding domains of LigB as vaccine candidates against leptospirosis in a hamster model.
    Cao Y; Faisal SM; Yan W; Chang YC; McDonough SP; Zhang N; Akey BL; Chang YF
    Vaccine; 2011 Oct; 29(43):7379-86. PubMed ID: 21803087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recombinant BCG strains expressing chimeric proteins derived from Leptospira protect hamsters against leptospirosis.
    Oliveira TL; Rizzi C; da Cunha CEP; Dorneles J; Seixas Neto ACP; Amaral MG; Hartwig DD; Dellagostin OA
    Vaccine; 2019 Feb; 37(6):776-782. PubMed ID: 30630695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of protective immunity of Leptospira immunoglobulin like protein A (LigA) DNA vaccine against challenge in hamsters.
    Faisal SM; Yan W; Chen CS; Palaniappan RU; McDonough SP; Chang YF
    Vaccine; 2008 Jan; 26(2):277-87. PubMed ID: 18055070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification and characterization of OmpA-like proteins as novel vaccine candidates for Leptospirosis.
    Yan W; Faisal SM; McDonough SP; Chang CF; Pan MJ; Akey B; Chang YF
    Vaccine; 2010 Mar; 28(11):2277-83. PubMed ID: 20064477
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A LigA three-domain region protects hamsters from lethal infection by Leptospira interrogans.
    Coutinho ML; Choy HA; Kelley MM; Matsunaga J; Babbitt JT; Lewis MS; Aleixo JA; Haake DA
    PLoS Negl Trop Dis; 2011 Dec; 5(12):e1422. PubMed ID: 22180800
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chimeric lipoproteins for leptospirosis vaccine: immunogenicity and protective potential.
    Tapajóz RCS; Santos FDS; de Oliveira NR; Maia MAC; Seixas Neto ACP; Maiocchi LV; Souza PHFC; Oliveira TL; Dellagostin OA
    Appl Microbiol Biotechnol; 2024 Jul; 108(1):424. PubMed ID: 39037584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antigenic potential of a recombinant polyvalent DNA vaccine against pathogenic leptospiral infection.
    Garba B; Bahaman AR; Zakaria Z; Bejo SK; Mutalib AR; Bande F; Suleiman N
    Microb Pathog; 2018 Nov; 124():136-144. PubMed ID: 30138761
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.